Right now the FDA does not allow the plasma of those vaccinated to be used. The reason why is because the vaccine causes spike antibodies, and for convalescent plasma, they need nucleocapsid antibodies.
From
To
Scientists are beginning a new study to tell if the blood plasma of COVID-19 survivors might help prevent infection in the first place.
SIH is identifying patients that may be good candidates for Convalescent Plasma Therapy.